My Portfolio
+
LINK YOUR PORTFOLIO

Pfizer Ltd PFIZER-IN:National Stock Exchange of India

*Data is delayed | Exchange | INR
Last | 06/03/26 IST
4,465.50UNCH (UNCH)
52 week range
4,449.20 - 5,873.50
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close4,465.50
  • 52 Week High5,873.50
  • 52 Week High Date08/18/25
  • 52 Week Low4,449.20
  • 52 Week Low Date06/03/26

Latest On Pfizer Ltd

Key Stats

  • Market Cap204.286B
  • Shares Out45.75M
  • 10 Day Average Volume0.02M
  • Dividend75.00
  • Dividend Yield1.68%
  • Beta0.64

Latest On Pfizer Ltd

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close4,465.50
  • 52 Week High5,873.50
  • 52 Week High Date08/18/25
  • 52 Week Low4,449.20
  • 52 Week Low Date06/03/26
  • Market Cap204.286B
  • Shares Out45.75M
  • 10 Day Average Volume0.02M
  • Dividend75.00
  • Dividend Yield1.68%
  • Beta0.64

RATIOS/PROFITABILITY

  • EPS (TTM)157.92
  • P/E (TTM)28.28
  • Fwd P/E (NTM)-
  • EBITDA (TTM)9.041B
  • ROE (TTM)17.16%
  • Revenue (TTM)25.197B
  • Gross Margin (TTM)64.90%
  • Net Margin (TTM)28.67%
  • Debt To Equity (MRQ)1.67%

EVENTS

  • Earnings Date-
  • Ex Div Date07/17/2026
  • Div Amount75.00
  • Split Date-
  • Split Factor-

Content From Our Affiliates

There is no recent news for this security.

Related Video

Chart Master: A breakout could signal more upside for beaten-down pharma stocks
VIDEO3:4603:46
Chart Master: A breakout could signal more upside for beaten-down pharma stocks

Profile

MORE
Pfizer Limited (Pfizer) is an India-based multinational pharmaceutical company focusing on therapy in four business categories, namely, Vaccines, Hospitals, Internal Medicine, and Inflammation and Immunology. Pfizer’s Vaccines Division focuses on Prevenar 13, a Pneumococcal Conjugate Vaccine approved for administering to individuals of all ages against pneumococcal disease, an infection caused by streptococcus pneumoniae bacteria. Internal Medicine portfolio includes...
Pradip Shah Ph.D.
Non-Executive Non-Independent Chairman of the Board
Amit Agarwal
Chief Financial Officer, Executive Director - Finance
Address
The Capital, 1802 / 1901, Plot No. C-70,
G Block, Bandra Kurla Complex, Bandra Ea
Mumbai
400051
India